Essig Stuart's Form 4 filing
Integra Lifesciences Holdings Corp (IART) · filed May 24, 2024
- Accession no.
- 0000917520-24-000076
- Filed
- May 24, 2024
- Trade date
- May 23, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $1.50M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Essig StuartCIK 0001187574 | Director, Officer (Exec. Chairman of the Board) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 23, 2024 | Common Stock | PPurchaseAcquired | +52,641 | $28.49F1 | +$1,499,742.09 | 487,922 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price shown above represents the weighted average price of the shares purchased. The range of the purchase prices was $28.31 to $28.66 The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in footnote (1) to this Form 4.
Referenced by the price of 1 transaction in Table I.